Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P. Stockman

ARCTIC: Durvalumab With or Without Tremelimumab as Third-Line or Later Treatment for Metastatic Non-Small Cell Lung Cancer

Annals of Oncology

English

Related publications

Anti-Pd-1 Therapy Plus Chemotherapy and/or Bevacizumab as Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer

Journal of Cancer

English

Treatment Paradigms for Patients With Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line

Current Oncology

English

Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice

Clinical Colorectal Cancer

Gastroenterology

English

Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer

Cancer Research

Gastroenterology

English

Radiotherapy With or Without Concomitant Chemotherapy as Pre- Or Postoperative Therapy in Non-Small Cell Lung Cancer

Journal of Cancer Science & Therapy

English

Durvalumab for Non-Resectable Stage IIIB Non-Small Cell Lung Cancer—a Small Step or a Big Leap?

Translational Lung Cancer Research

English

Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer

Clinical Cancer Research

Cancer Research

English

Tasisulam Sodium (LY573636 Sodium) as Third-Line Treatment in Patients With Unresectable, Metastatic Non–Small-Cell Lung Cancer: A Phase-Ii Study

Journal of Thoracic Oncology

Respiratory Medicine

English

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-Small Cell Lung Cancer

Frontiers in Oncology

Cancer Research

English